Skip to main content
Mycobiology logoLink to Mycobiology
. 2013 Jun 30;41(2):67–72. doi: 10.5941/MYCO.2013.41.2.67

Lipolytic Enzymes Involved in the Virulence of Human Pathogenic Fungi

Minji Park 1, Eunsoo Do 1, Won Hee Jung 1,
PMCID: PMC3714442  PMID: 23874127

Abstract

Pathogenic microbes secrete various enzymes with lipolytic activities to facilitate their survival within the host. Lipolytic enzymes include extracellular lipases and phospholipases, and several lines of evidence have suggested that these enzymes contribute to the virulence of pathogenic fungi. Candida albicans and Cryptococcus neoformans are the most commonly isolated human fungal pathogens, and several biochemical and molecular approaches have identified their extracellular lipolytic enzymes. The role of lipases and phospholipases in the virulence of C. albicans has been extensively studied, and these enzymes have been shown to contribute to C. albicans morphological transition, colonization, cytotoxicity, and penetration to the host. While not much is known about the lipases in C. neoformans, the roles of phospholipases in the dissemination of fungal cells in the host and in signaling pathways have been described. Lipolytic enzymes may also influence the survival of the lipophilic cutaneous pathogenic yeast Malassezia species within the host, and an unusually high number of lipase-coding genes may complement the lipid dependency of this fungus. This review briefly describes the current understanding of the lipolytic enzymes in major human fungal pathogens, namely C. albicans, C. neoformans, and Malassezia spp.

Keywords: Candida albicans, Cryptococcus neoformans, Lipase, Lipolytic enzyme, Malassezia, Phospholipase


Pathogenic microbes secrete hydrolytic enzymes that enable them to breach and invade host tissues. The most highly recognized extracellular hydrolytic enzymes include proteinases and the lipolytic enzymes, lipases and phospholipases. Numerous studies have focused on the functions of proteinases in the virulence of pathogenic microbes and have suggested that proteinase activities alter the permeability of the epithelial barrier and induce inflammatory responses [1]. In contrast, the roles of lipases and phospholipases in virulence remain widely unexplored.

Lipases catalyze the hydrolysis of ester bonds of triacylglycerols, resulting in the release of fatty acids. In almost all organisms, lipases play essential roles in lipid metabolism, including digestion, transport, and the processing of dietary lipids. In addition, a number of studies have shown that human microbial pathogens utilize lipases in their pathogenesis. Lipase activity is required for the colonization and persistence of the bacterial pathogens Propionibacterium acnes and Staphylococcus epidermidis on human skin [2, 3]. Furthermore, the lipases of Staphylococcus aureus and Pseudomonas aeruginosa have been shown to interfere with the immune response of host cells [4]. Mycobacterium tuberculosis also relies on its lipases to hydrolyze host cell lipids during infection, and then uses the released fatty acids as its long-term energy source [5]. Lipolytic enzymes have also been implicated in the virulence of fungal pathogens; the contribution of lipases in fungal pathogenesis has been extensively characterized in Candida spp. C. albicans possesses at least 10 lipase-encoding genes, the expression of which is largely influenced by the stage of infection [6]. In C. parapsilosis, lipases are responsible for the destruction of epidermal and epithelial tissues [7]. Lipases also play important roles in the virulence of skin-associated lipophilic fungal pathogens of the Malassezia spp. The gene that encodes for lipases in M. furfur, M. pachydermatis, and M. globosa has been identified, and recent genome sequencing efforts have revealed at least 14 lipase-encoding genes in M. globosa [8-10].

Phospholipases hydrolyze one or more ester linkages in glycerophospholipids, resulting in the release of free fatty acids [11]. In general, phospholipases are classified into 5 subclasses: A (PLA), A2 (PLA2), B (PLB), C (PLC), and D (PLD), depending on the specific ester bond they target [11]. Evidence indicating that phospholipases may contribute to host cell penetration, injury, and lysis has emerged from the study of parasitic protozoa such as Toxoplasma gondii and Entamoeba histolytica, and bacterial pathogens of the Rickettsia spp. and S. aureus, and fungal pathogens C. albicans, C. neoformans, and Malassezia spp. [11, 12]. The type of phospholipases associated with pathogenicity varies among organisms, but the activities of these enzymes commonly result in the destabilization of the host cell membrane and the release of lipid second messengers [12, 13]. Thus, accumulating data have suggested the importance of lipases and phospholipases in virulence of pathogenic microbes. In this review, we summarize current findings on the roles of lipases and phospholipases in virulence of major fungal pathogens, C. albicans and C. neoformans, as well as the recently emerging cutaneous opportunistic pathogen, Malassezia spp.

LIPOLYTIC ENZYMES OF CANDIDA ALBICANS

C. albicans is the most prevalent cause of hospital-acquired infectious fungal diseases. For the immunocompromised individual, this fungus causes life-threatening systemic diseases, and its mortality may be as high as 50%. Superficial fungal infections such as thrush and vaginitis are also caused by C. albicans [14, 15]. The secreted lipase activity of C. albicans was first detected by Fu et al. [16]. A subsequent genomic library screening has identified the gene, LIP1 that encodes a lipase containing the conserved Gly-X-Ser-X-Gly motif. Non-albicans Candida spp. such as C. parapsilosis, C. tropicalis, and C. krusei have also been shown to possess a gene that is orthologous to C. albicans LIP1. The discovery of LIP1 in C. albicans has led to the identification of additional 9 lipase-encoding genes, LIP2~LIP10, wherein the sequence is highly conserved (up to 80% sequence identity). The contribution of the lipase to C. albicans persistence and virulence has also been suggested, based on the observation of expression of all 10 lipases during the yeast-hypha transition and the detection of transcription of lipases such as LIP5, LIP6, LIP8, and LIP9 during experimental infections [6]. The differential expression of LIP1~LIP10 during colonization in experimental models and in patient specimens has also been previously reported [17, 18]. Furthermore, an additional ~70 kDa extracellular lipase activity has been detected and shown to exert cytotoxic effects in the host macrophages and hepatocytes, presumably through the production of reactive oxygen species [19, 20].

Extracellular phospholipases also play major roles in the virulence of C. albicans, and a previous study has shown that approximately 79% of clinically isolated C. albicans strains secrete the enzyme [21]. PLA, PLB, PLC, and PLD have been detected in C. albicans, and the genes encoding these proteins have been identified [22-26]. PLB1 encodes PLB and was the first phospholipase gene identified in C. albicans. A strain lacking PLB1 has been generated and used in the assessment of the virulent attributes of PLB. Although PLB1 did not influence the growth and morphology of the fungus or its adherence to the host cell, the virulence of the null mutant was significantly attenuated in murine models of disseminated candidiasis [24, 27]. The second gene, PLB2, which encodes for PLB, has also been identified in C. albicans [28]. However, its role may be marginal, because in vivo analysis of 137 human subjects with oral and vaginal candidiasis revealed that only PLB1 but not PLB2 expression correlates with human oral infections [29]. To date, 3 genes, PLC1, PLC2, and PLC3, which encode PLC, have been identified in C. albicans. Among these, PLC1 has been determined as essential, whereas PLC2 and PLC3 are not. Although the heterozygous plc1/PLC1 mutant and the mutant lacking PLC2 and PLC3 were deficient in hyphal formation, the functions of PLC were shown to be dispensable for virulence [30]. PLD is involved in diverse essential cellular processes, including sporulation, growth, and membrane lipid synthesis in the non-pathogenic model yeast Saccharomyces cerevisiae [31-34]. Relevant roles for PLD in C. albicans have been previously demonstrated by McLain and Dolan [35], and the gene encoding the protein with a highly conserved PLD motif was identified and designated as PLD1 [36]. An attenuation of virulence was observed in mice orally infected with a PLD1-deficient mutant, thus suggesting that PLD may play a role in the pathogenesis of C. albicans [26]. Accumulating data therefore indicate that lipolytic enzymes, such as lipases and phospholipases, play critical roles in virulence of C. albicans.

LIPOLYTIC ENZYMES OF CRYPTOCOCCUS NEOFORMANS

C. neoformans is an encapsulated human pathogenic fungus that causes pulmonary cryptococcosis and cryptococcal meningitis mainly in immunocompromised individuals such as acquired immunodeficiency syndrome (AIDS) patients [37, 38]. To date, little information on the functions and the roles of lipases in C. neoformans is available, although genome sequence data have indicated that the fungus possesses at least 3 lipase genes. Unlike C. albicans, none of the lipase-encoding genes in C. neoformans produce a protein with a signal peptide and no extracellular lipase activity has been detected from a clinically isolated C. neoformans strain [39]. In contrast, numerous studies have suggested that phospholipases play a role in the physiology and virulence of C. neoformans. Early studies have reported that clinically isolated C. neoformans strains secrete phospholipases, and a characterization of their activity has identified these as mainly phospholipase B and suggested that the activity of this enzyme correlates with the capsule size and virulence of the fungus [40-42]. Phospholipase A activity has also been previously reported, although the gene encoding this particular enzyme and its virulence attributes have not been established [43, 44]. The gene encoding phospholipase B, PLB1, has been identified and a deletion mutant has been generated through targeted gene disruption. The plb1 mutant displayed no particular phenotype when it was examined for the expression of major virulence factors such as the ability to grow at 37℃, capsule formation, and melanin synthesis. However, deletion of PLB1 resulted in attenuated virulence in the mouse inhalation model and the rabbit meningitis model, indicating that PLB contributes to the pathogenicity of C. neoformans [13]. The importance of PLB in the virulence of C. neoformans was further confirmed by the observation of glycerophosphorylcholine (GPC) in lesions extracted from animals infected with C. neoformans. The occurrence of GPC was consistent with the generation of hydrolysis products from the host phospholipids through the action of PLB in C. neoformans [45]. Furthermore, the study suggested that PLB activity is required for the initiation of interstitial pulmonary infections and for the dissemination from the lung through the lymphatics and blood, whereas the dissemination of cryptococci to the central nervous system was shown to be independent of the enzyme [46]. C. neoformans PLB contains an N-terminal secretory leader peptide and acquires a glycosylphosphatidylinositol (GPI) anchor that facilitates its attachment to the plasma membrane prior to secretion [47]. PLB in C. neoformans is also extensively glycosylated at its N-terminal, which influences membrane association and the secretion of the enzyme [48]. Chayakulkeeree et al. [49] demonstrated that cleavage of PLB is mediated by phosphatidylinositol-specific phospholipase C (PI-PLC), which is encoded by two genes, PLC1 and PLC2. The mutant that lacks either PLC1 or PLC2 was constructed to characterize the functions of PI-PLC in C. neoformans. While no particular phenotypic characteristic was observed in the plc2 mutant, the effect of the deletion of PLC1 was dramatic. The plc1 mutant showed an impaired growth at 37℃, protein secretion, and melanin production, and was avirulent in a murine inhalation model of cryptococcosis. A correlation between PLC and the protein kinase C/mitogen-activated protein kinase signaling pathway has also been suggested and has further confirmed the significant roles of PLC in the physiology and pathogenicity of C. neoformans.

LIPOLYTIC ENZYMES OF MALASSEZIA SPP.

Malassezia spp. are associated with various dermatological diseases, including seborrheic dermatitis, dandruff, atopic dermatitis, and pityriasis versicolor [50]. To date, 14 spp. have been identified and all Malassezia spp., except M. pachydermatis, are known to be obligatorily lipid-dependent [51]. The lipophilic nature of Malassezia spp. may be attributable to its inability to synthesize myristic acid, which is the precursor of long chain fatty acids. Recent genome analysis of M. globosa has revealed the absence of a gene that influences fatty acid synthesis [52]. The genome of M. globosa contains a number of genes that encode for lipolytic enzymes, including 14 lipases and 9 phospholipases, which may compensate for the lipid dependency of the fungus. A significantly higher lipid content in the cell wall of Malassezia spp. compared to non-pathogenic fungi such as S. cerevisiae has been previously reported, and the lipid microfibrillar layer of the Malassezia cell has been shown to down-regulate the inflammatory immune response, implying that the lipid dependency of the fungus might play a role in virulence [53, 54].

The importance of the lipase function was first studied in M. furfur. Its enzyme activity was initially detected in the insoluble fraction of the cells, and its optimum pH was determined as acidic. A positive correlation between lipase activity and cell growth has also been observed [55]. Brunke and Hube [56] cloned and characterized the gene, MfLIP1, which encodes for the extracellular lipase in M. furfur. A protein sequence analysis has shown that MfLip1 contains the conserved lipase motif, Gly-X-Ser-X-Gly, and is similar to lipases in C. albicans. The protein contains a signal peptide at its N-terminus, but not a transmembrane domain or a GPI-anchor motif. The MfLIP1 gene might not belong to other lipase gene families in the genome of M. furfur, because no signal was detected during Southern blot analysis by using the cDNA fragment of the gene as a probe. Interestingly however, the same approach using the genome of M. pachydermatis displayed signals, thus suggesting the presence of an ortholog. Moreover, heterologous expression of the cDNA of MfLIP1 in Pichia pastoris has suggested that the recombinant MfLip1 is most active at 40℃ and its optimal pH was 5.8.

The gene encoding for the extracellular lipase in M. pachydermatis has been cloned and characterized [57]. M. globosa, one of the most frequently isolated Malassezia spp. from patients with dandruff and seborrheic dermatitis, also displayed extracellular lipase activity. Although recent genome analysis has revealed there are at least 14 lipase-encoding genes, only one gene, MgLIP1, has been identified. Similar to lipases in other Malassezia spp., the protein product of MgLIP1 contains the conserved lipase motif and the signal peptide. The regulation of gene expression has also been investigated, with MgLIP1 transcription levels regulated by its growth phase in vitro. The expression of MgLIP1 was higher in the late log phase compared to early log and stationary phases. Moreover, the expression of MgLIP1 was detected in human scalp specimens, indicating that lipases may play a key role in virulence of M. globosa [8]. The structure of MgLip1 has been proposed, and its substrates have been reported to be strictly specific for mono- and diacylglycerol, but not triacylglycerol [58, 59]. Other than MgLip1, additional extracellular lipase activity has been identified. The enzyme has been designated as MgLip2 and optimal activity has been observed at 30℃ and pH 5.0 [60]. Interestingly, a recent study compared the extracellular lipase activity of several Malassezia spp., with M. globosa showing the highest lipase activity [61].

Current information on phospholipases in Malassezia spp. is limited. Juntachai et al. [61] detected extracellular phospholipase activities in M. furfur, M. pachydermatis, M. slooffiae, M. sympodialis, M. globosa, M. restricta, and M. obtusa. However, enzyme activity was higher only in M. pachydermatis, which is lipid-independent and has been normally isolated in dogs. The phospholipase activity in Malassezia spp. associated with humans is relatively low, which implies that the role of secreted phospholipases in Malassezia spp. might be marginal.

CONCLUSIONS

Numerous experimental data have revealed the contribution of lipolytic enzymes in the virulence of human pathogenic fungi (Table 1). C. albicans and C. neoformans have served as good model systems for investigating the functions and roles of specific enzymes in fungal pathogenesis. Lipolytic enzymes, which include secreted lipases and phospholipases, have been shown to influence growth, morphology, adherence, and dissemination of fungal cells across the host. Several studies have also emphasized the significance of lipolytic enzymes in Malassezia spp., although no genetic tool has been developed. Secreted lipases are key players and may complement lipid dependency of Malassezia spp. Therefore, a greater effort in understanding the roles of lipolytic enzymes in fungal pathogens is warranted.

Table 1.

Genes encoding lipases and phospholipases in major human fungal pathogens

graphic file with name mb-41-67-i001.jpg

N/A, not available.

aGenes have been identified, but the function and virulence attributes have not been established.

bThe null mutant was as virulent as the wild-type in the experimental animal model.

ACKNOWLEDGEMENTS

This research was supported by the Chung-Ang University Research Scholarship Grants in 2013.

References

  • 1.Yike I. Fungal proteases and their pathophysiological effects. Mycopathologia. 2011;171:299–323. doi: 10.1007/s11046-010-9386-2. [DOI] [PubMed] [Google Scholar]
  • 2.Gribbon EM, Cunliffe WJ, Holland KT. Interaction of Propionibacterium acnes with skin lipids in vitro. J Gen Microbiol. 1993;139:1745–1751. doi: 10.1099/00221287-139-8-1745. [DOI] [PubMed] [Google Scholar]
  • 3.Farrell AM, Foster TJ, Holland KT. Molecular analysis and expression of the lipase of Staphylococcus epidermidis. J Gen Microbiol. 1993;139:267–277. doi: 10.1099/00221287-139-2-267. [DOI] [PubMed] [Google Scholar]
  • 4.Jaeger KE, Ransac S, Dijkstra BW, Colson C, van Heuvel M, Misset O. Bacterial lipases. FEMS Microbiol Rev. 1994;15:29–63. doi: 10.1111/j.1574-6976.1994.tb00121.x. [DOI] [PubMed] [Google Scholar]
  • 5.Singh G, Singh G, Jadeja D, Kaur J. Lipid hydrolizing enzymes in virulence: Mycobacterium tuberculosis as a model system. Crit Rev Microbiol. 2010;36:259–269. doi: 10.3109/1040841X.2010.482923. [DOI] [PubMed] [Google Scholar]
  • 6.Hube B, Stehr F, Bossenz M, Mazur A, Kretschmar M, Schäfer W. Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch Microbiol. 2000;174:362–374. doi: 10.1007/s002030000218. [DOI] [PubMed] [Google Scholar]
  • 7.Gácser A, Schäfer W, Nosanchuk JS, Salomon S, Nosanchuk JD. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet Biol. 2007;44:1336–1341. doi: 10.1016/j.fgb.2007.02.002. [DOI] [PubMed] [Google Scholar]
  • 8.DeAngelis YM, Saunders CW, Johnstone KR, Reeder NL, Coleman CG, Kaczvinsky JR, Jr, Gale C, Walter R, Mekel M, Lacey MP, et al. Isolation and expression of a Malassezia globosa lipase gene, LIP1. J Invest Dermatol. 2007;127:2138–2146. doi: 10.1038/sj.jid.5700844. [DOI] [PubMed] [Google Scholar]
  • 9.Mancianti F, Rum A, Nardoni S, Corazza M. Extracellular enzymatic activity of Malassezia spp. isolates. Mycopathologia. 2001;149:131–135. doi: 10.1023/a:1007237408748. [DOI] [PubMed] [Google Scholar]
  • 10.Muhsin TM, Aubaid AH, al-Duboon AH. Extracellular enzyme activities of dermatophytes and yeast isolates on solid media. Mycoses. 1997;40:465–469. doi: 10.1111/j.1439-0507.1997.tb00186.x. [DOI] [PubMed] [Google Scholar]
  • 11.Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev. 2000;13:122–143. doi: 10.1128/cmr.13.1.122-143.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ibrahim AS, Mirbod F, Filler SG, Banno Y, Cole GT, Kitajima Y, Edwards JE, Jr, Nozawa Y, Ghannoum MA. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun. 1995;63:1993–1998. doi: 10.1128/iai.63.5.1993-1998.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Cox GM, McDade HC, Chen SC, Tucker SC, Gottfredsson M, Wright LC, Sorrell TC, Leidich SD, Casadevall A, Ghannoum MA, et al. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol. 2001;39:166–175. doi: 10.1046/j.1365-2958.2001.02236.x. [DOI] [PubMed] [Google Scholar]
  • 14.Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133–163. doi: 10.1128/CMR.00029-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005;41:1232–1239. doi: 10.1086/496922. [DOI] [PubMed] [Google Scholar]
  • 16.Fu Y, Ibrahim AS, Fonzi W, Zhou X, Ramos CF, Ghannoum MA. Cloning and characterization of a gene (LIP1) which encodes a lipase from the pathogenic yeast Candida albicans. Microbiology. 1997;143(Pt 2):331–340. doi: 10.1099/00221287-143-2-331. [DOI] [PubMed] [Google Scholar]
  • 17.Stehr F, Felk A, Gácser A, Kretschmar M, Mähnss B, Neuber K, Hybe B, Schäfer W. Expression analysis of the Candida albicans lipase gene family during experimental infections and in patient samples. FEMS Yeast Res. 2004;4:401–408. doi: 10.1016/S1567-1356(03)00205-8. [DOI] [PubMed] [Google Scholar]
  • 18.Schofield DA, Westwater C, Warner T, Balish E. Differential Candida albicans lipase gene expression during alimentary tract colonization and infection. FEMS Microbiol Lett. 2005;244:359–365. doi: 10.1016/j.femsle.2005.02.015. [DOI] [PubMed] [Google Scholar]
  • 19.Paraje MG, Correa SG, Renna MS, Theumer M, Sotomayor CE. Candida albicans-secreted lipase induces injury and steatosis in immune and parenchymal cells. Can J Microbiol. 2008;54:647–659. doi: 10.1139/w08-048. [DOI] [PubMed] [Google Scholar]
  • 20.Paraje MG, Correa SG, Albesa I, Sotomayor CE. Lipase of Candida albicans induces activation of NADPH oxidase and L-arginine pathways on resting and activated macrophages. Biochem Biophys Res Commun. 2009;390:263–268. doi: 10.1016/j.bbrc.2009.09.104. [DOI] [PubMed] [Google Scholar]
  • 21.Samaranayake LP, Raeside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia. 1984;22:201–207. [PubMed] [Google Scholar]
  • 22.Barrett-Bee K, Hayes Y, Wilson RG, Ryley JF. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol. 1985;131:1217–1221. doi: 10.1099/00221287-131-5-1217. [DOI] [PubMed] [Google Scholar]
  • 23.Banno Y, Yamada T, Nozawa Y. Secreted phospholipases of the dimorphic fungus, Candida albicans: separation of three enzymes and some biological properties. Sabouraudia. 1985;23:47–54. doi: 10.1080/00362178585380081. [DOI] [PubMed] [Google Scholar]
  • 24.Hoover CI, Jantapour MJ, Newport G, Agabian N, Fisher SJ. Cloning and regulated expression of the Candida albicans phospholipase B (PLB1) gene. FEMS Microbiol Lett. 1998;167:163–169. doi: 10.1111/j.1574-6968.1998.tb13223.x. [DOI] [PubMed] [Google Scholar]
  • 25.Pugh D, Cawson RA. The cytochemical localization of phospholipase in Candida albicans infecting the chick chorio-allantoic membrane. Sabouraudia. 1977;15:29–35. [PubMed] [Google Scholar]
  • 26.Hube B, Hess D, Baker CA, Schaller M, Schäfer W, Dolan JW. The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiology. 2001;147(Pt 4):879–889. doi: 10.1099/00221287-147-4-879. [DOI] [PubMed] [Google Scholar]
  • 27.Leidich SD, Ibrahim AS, Fu Y, Koul A, Jessup C, Vitullo J, Fonzi W, Mirbod F, Nakashima S, Nozawa Y, et al. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem. 1998;273:26078–26086. doi: 10.1074/jbc.273.40.26078. [DOI] [PubMed] [Google Scholar]
  • 28.Sugiyama Y, Nakashima S, Mirbod F, Kanoh H, Kitajima Y, Ghannoum MA, Nozawa Y. Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans. Med Mycol. 1999;37:61–67. [PubMed] [Google Scholar]
  • 29.Naglik JR, Rodgers CA, Shirlaw PJ, Dobbie JL, Fernandes-Naglik LL, Greenspan D, Agabian N, Challacombe SJ. Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J Infect Dis. 2003;188:469–479. doi: 10.1086/376536. [DOI] [PubMed] [Google Scholar]
  • 30.Kunze D, Melzer I, Bennett D, Sanglard D, MacCallum D, Nörskau J, Coleman DC, Odds FC, Schäfer W, Hube B. Functional analysis of the phospholipase C gene CaPLC1 and two unusual phospholipase C genes, CaPLC2 and CaPLC3, of Candida albicans. Microbiology. 2005;151(Pt 10):3381–3394. doi: 10.1099/mic.0.28353-0. [DOI] [PubMed] [Google Scholar]
  • 31.Ella KM, Dolan JW, Qi C, Meier KE. Characterization of Saccharomyces cerevisiae deficient in expression of phospholipase D. Biochem J. 1996;314(Pt 1):15–19. doi: 10.1042/bj3140015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Waksman M, Eli Y, Liscovitch M, Gerst JE. Identification and characterization of a gene encoding phospholipase D activity in yeast. J Biol Chem. 1996;271:2361–2364. doi: 10.1074/jbc.271.5.2361. [DOI] [PubMed] [Google Scholar]
  • 33.Sreenivas A, Patton-Vogt JL, Bruno V, Griac P, Henry SA. A role for phospholipase D (Pld1p) in growth, secretion, and regulation of membrane lipid synthesis in yeast. J Biol Chem. 1998;273:16635–16638. doi: 10.1074/jbc.273.27.16635. [DOI] [PubMed] [Google Scholar]
  • 34.Xie Z, Fang M, Rivas MP, Faulkner AJ, Sternweis PC, Engebrecht JA, Bankaitis VA. Phospholipase D activity is required for suppression of yeast phosphatidylinositol transfer protein defects. Proc Natl Acad Sci U S A. 1998;95:12346–12351. doi: 10.1073/pnas.95.21.12346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.McLain N, Dolan JW. Phospholipase D activity is required for dimorphic transition in Candida albicans. Microbiology. 1997;143(Pt 11):3521–3526. doi: 10.1099/00221287-143-11-3521. [DOI] [PubMed] [Google Scholar]
  • 36.Kanoh H, Nakashima S, Zhao Y, Sugiyama Y, Kitajima Y, Nozawa Y. Molecular cloning of a gene encoding phospholipase D from the pathogenic and dimorphic fungus, Candida albicans. Biochim Biophys Acta. 1998;1398:359–364. doi: 10.1016/s0167-4781(98)00067-0. [DOI] [PubMed] [Google Scholar]
  • 37.Kronstad JW, Attarian R, Cadieux B, Choi J, D'Souza CA, Griffiths EJ, Geddes JM, Hu G, Jung WH, Kretschmer M, et al. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol. 2011;9:193–203. doi: 10.1038/nrmicro2522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23:525–530. doi: 10.1097/QAD.0b013e328322ffac. [DOI] [PubMed] [Google Scholar]
  • 39.García-Martos P, Marín P, Hernández-Molina JM, García-Agudo L, Aoufi S, Mira J. Extracellular enzymatic activity in 11 Cryptococcus species. Mycopathologia. 2001;150:1–4. doi: 10.1023/a:1010868223582. [DOI] [PubMed] [Google Scholar]
  • 40.Chen SC, Muller M, Zhou JZ, Wright LC, Sorrell TC. Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis. 1997;175:414–420. doi: 10.1093/infdis/175.2.414. [DOI] [PubMed] [Google Scholar]
  • 41.Vidotto V, Sinicco A, Di Fraia D, Cardaropoli S, Aoki S, Ito-Kuwa S. Phospholipase activity in Cryptococcus neoformans. Mycopathologia. 1996;136:119–123. doi: 10.1007/BF00438916. [DOI] [PubMed] [Google Scholar]
  • 42.Chen SC, Wright LC, Santangelo RT, Muller M, Moran VR, Kuchel PW, Sorrell TC. Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun. 1997;65:405–411. doi: 10.1128/iai.65.2.405-411.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Wright LC, Santangelo RM, Ganendren R, Payne J, Djordjevic JT, Sorrell TC. Cryptococcal lipid metabolism: phospholipase B1 is implicated in transcellular metabolism of macrophage-derived lipids. Eukaryot Cell. 2007;6:37–47. doi: 10.1128/EC.00262-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ganendren R, Widmer F, Singhal V, Wilson C, Sorrell T, Wright L. In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans. Antimicrob Agents Chemother. 2004;48:1561–1569. doi: 10.1128/AAC.48.5.1561-1569.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Himmelreich U, Allen C, Dowd S, Malik R, Shehan BP, Mountford C, Sorrell TC. Identification of metabolites of importance in the pathogenesis of pulmonary cryptococcoma using nuclear magnetic resonance spectroscopy. Microbes Infect. 2003;5:285–290. doi: 10.1016/s1286-4579(03)00028-5. [DOI] [PubMed] [Google Scholar]
  • 46.Santangelo R, Zoellner H, Sorrell T, Wilson C, Donald C, Djordjevic J, Shounan Y, Wright L. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect Immun. 2004;72:2229–2239. doi: 10.1128/IAI.72.4.2229-2239.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Djordjevic JT, Del Poeta M, Sorrell TC, Turner KM, Wright LC. Secretion of cryptococcal phospholipase B1 (PLB1) is regulated by a glycosylphosphatidylinositol (GPI) anchor. Biochem J. 2005;389(Pt 3):803–812. doi: 10.1042/BJ20050063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Turner KM, Wright LC, Sorrell TC, Djordjevic JT. N-linked glycosylation sites affect secretion of cryptococcal phospholipase B1, irrespective of glycosylphosphatidylinositol anchoring. Biochim Biophys Acta. 2006;1760:1569–1579. doi: 10.1016/j.bbagen.2006.07.002. [DOI] [PubMed] [Google Scholar]
  • 49.Chayakulkeeree M, Sorrell TC, Siafakas AR, Wilson CF, Pantarat N, Gerik KJ, Boadle R, Djordjevic JT. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans. Mol Microbiol. 2008;69:809–826. doi: 10.1111/j.1365-2958.2008.06310.x. [DOI] [PubMed] [Google Scholar]
  • 50.Ashbee HR. Recent developments in the immunology and biology of Malassezia species. FEMS Immunol Med Microbiol. 2006;47:14–23. doi: 10.1111/j.1574-695X.2006.00057.x. [DOI] [PubMed] [Google Scholar]
  • 51.Hort W, Mayser P. Malassezia virulence determinants. Curr Opin Infect Dis. 2011;24:100–105. doi: 10.1097/QCO.0b013e328342f787. [DOI] [PubMed] [Google Scholar]
  • 52.Xu J, Saunders CW, Hu P, Grant RA, Boekhout T, Kuramae EE, Kronstad JW, Deangelis YM, Reeder NL, Johnstone KR, et al. Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogens. Proc Natl Acad Sci U S A. 2007;104:18730–18735. doi: 10.1073/pnas.0706756104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Thompson E, Colvin JR. Composition of the cell wall of Pityrosporum ovale (Bizzozero) Castellani and Chalmers. Can J Microbiol. 1970;16:263–265. doi: 10.1139/m70-048. [DOI] [PubMed] [Google Scholar]
  • 54.Kesavan S, Holland KT, Ingham E. The effects of lipid extraction on the immunomodulatory activity of Malassezia species in vitro. Med Mycol. 2000;38:239–247. doi: 10.1080/mmy.38.3.239.247. [DOI] [PubMed] [Google Scholar]
  • 55.Ran Y, Yoshiike T, Ogawa H. Lipase of Malassezia furfur: some properties and their relationship to cell growth. J Med Vet Mycol. 1993;31:77–85. doi: 10.1080/02681219380000081. [DOI] [PubMed] [Google Scholar]
  • 56.Brunke S, Hube B. MfLIP1, a gene encoding an extracellular lipase of the lipid-dependent fungus Malassezia furfur. Microbiology. 2006;152(Pt 2):547–554. doi: 10.1099/mic.0.28501-0. [DOI] [PubMed] [Google Scholar]
  • 57.Shibata N, Okanuma N, Hirai K, Arikawa K, Kimura M, Okawa Y. Isolation, characterization and molecular cloning of a lipolytic enzyme secreted from Malassezia pachydermatis. FEMS Microbiol Lett. 2006;256:137–144. doi: 10.1111/j.1574-6968.2006.00106.x. [DOI] [PubMed] [Google Scholar]
  • 58.Xu T, Liu L, Hou S, Xu J, Yang B, Wang Y, Liu J. Crystal structure of a mono- and diacylglycerol lipase from Malassezia globosa reveals a novel lid conformation and insights into the substrate specificity. J Struct Biol. 2012;178:363–369. doi: 10.1016/j.jsb.2012.03.006. [DOI] [PubMed] [Google Scholar]
  • 59.Liu L, Gao C, Lan D, Yang B, Wang Y. Molecular basis for substrate selectivity of a mono- and diacylglycerol lipase from Malassezia globosa. Biochem Biophys Res Commun. 2012;424:285–289. doi: 10.1016/j.bbrc.2012.06.108. [DOI] [PubMed] [Google Scholar]
  • 60.Juntachai W, Oura T, Kajiwara S. Purification and characterization of a secretory lipolytic enzyme, MgLIP2, from Malassezia globosa. Microbiology. 2011;157(Pt 12):3492–3499. doi: 10.1099/mic.0.054528-0. [DOI] [PubMed] [Google Scholar]
  • 61.Juntachai W, Oura T, Murayama SY, Kajiwara S. The lipolytic enzymes activities of Malassezia species. Med Mycol. 2009;47:477–484. doi: 10.1080/13693780802314825. [DOI] [PubMed] [Google Scholar]

Articles from Mycobiology are provided here courtesy of Korean Society of Mycology

RESOURCES